It has been reported that miR-451a is down regulated in glioma, and overexpression of miR-451a can target IKKβ via NF-κB signal pathway, thereby inhibiting the growth of glioma cells in vitro and in vivo74. The gene discussed is NFKB1; the disease is central nervous system cancer.